Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics RegisterEoghan McCarthy, Asad Zoma, Ian N Bruce et al.|Lara D. Veeken|2017Cited by 94
The prevalence of self-reported lower limb and foot health problems experienced by participants with systemic lupus erythematosus: Results of a UK national surveyLindsey Cherry, Anita Williams, Begonya Alcacer‐Pitarch et al.|Lupus|2016Cited by 26
Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprineJohn A. Reynolds, Caroline Gordon, Mary Gayed et al.|Lara D. Veeken|2022Cited by 20
Work participation, mobility and foot symptoms in people with systemic lupus erythematosus: findings of a UK national surveyMartin Stevens, Lindsey Cherry, Karen Walker‐Bone et al.|Journal of Foot and Ankle Research|2019Cited by 15
Revision to the musculoskeletal domain of the BILAG-2004 index to incorporate ultrasound findingsRobert D Sandler, Chee‐Seng Yee, Edward M Vital et al.|Lara D. Veeken|2023Cited by 12